[Form 4] ANALOG DEVICES INC Insider Trading Activity
Rhea-AI Filing Summary
Analog Devices chief accounting officer Michael Sondel reported routine equity compensation activity. He received a grant of 958 shares of common stock at $0.0000 per share, bringing his direct holdings to 14,919.29 shares. Separately, 778.289 shares were withheld at $310.92 per share to cover tax obligations on vested performance-based and time-based restricted stock units. Footnotes note PRSUs granted on April 3, 2023 were earned at 192.01% of target based on relative total shareholder return and are scheduled to vest on March 29, 2026 subject to continued employment.
Positive
- None.
Negative
- None.
Insights
Routine award and tax withholding with no open‑market trading.
Chief accounting officer Michael Sondel received an equity grant of 958 common shares, while 778.289 shares were withheld to satisfy taxes on vested RSUs and PRSUs. No open‑market buys or sells were reported; these are standard compensation mechanics.
Footnotes explain that performance-based RSUs granted on April 3, 2023 were earned at 192.01% of target based on relative total shareholder return, with shares scheduled to vest on March 29, 2026 if employment continues. This links awards to shareholder return but does not change the company’s financial outlook by itself.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Comm Stock - $.16-2/3 value | 958 | $0.00 | -- |
| Tax Withholding | Comm Stock - $.16-2/3 value | 778.289 | $310.92 | $242K |
Footnotes (1)
- Represents aggregate shares withheld to satisfy tax withholding obligations on 203 Performance-based Restricted Stock Units (PRSUs) and 1,599 Restricted Stock Units (RSUs) that vested on March 16, 2026. Represents shares of common stock of the Company earned in connection with PRSUs granted on April 3, 2023. The shares were earned based on the achievement of certain pre-established performance parameters relating to the Company's relative total shareholder return performance over a three-year period at 192.01% of target. The shares will vest on March 29, 2026, subject to the Reporting Person's continued employment with the Company.